Conference Chairs
Michael Graner
Associate Professor, University of Colorado Anschutz School of Medicine | 
Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University |
 Keynote Speakers
Fatah Kashanchi
Professor, George Mason University | 
Dolores Di Vizio
Professor, Cedars Sinai Medical Center | 
Alissa Weaver
Cornelius Vanderbilt Professor of Cell and Developmental Biology, Vanderbilt University Medical Center | 
Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Randolph Corteling
Head of Research, ReNeuron Ltd. |
|
My Mahoney
Professor and Vice Chair, Thomas Jefferson University |
OverviewSelectBIO EV-based Diagnostics, Delivery & Therapeutics 2021 Conference, February 25-26, 2021 San Diego brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
- Exosome/EV Engineering -- Engineered Exosomes for Delivery
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development
- Exosomes/EVs-derived from Stem Cells and their Role in Regenerative Medicine
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date. Registered
delegates receive full access to both the co-located concurrent conference
tracks, the co-located exhibit hall featuring companies from around the
world providing tools/technologies, products and services. Conference Presentations and Content Organization - Circulating Biomarkers 2021
- EV-based Diagnostics, Delivery and Therapeutics 2021
- EVs and Stem Cells 2021 -- Speakers from this Topic Area are in Sessions Embedded in the EV-based Diagnostics, Delivery and Therapeutics Track
Call for PapersIf you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now! Oral Presentation Submission Deadline: 30 November 2020 Call for PostersYou can also present your research on a poster while attending the meeting. Submit an abstract for consideration now! Poster Submission Deadline: 15 February 2021 Agenda Topics- Engineered Exosomes and Extracellular Vesicles (EVs) for Drug Delivery
- Engineering EVs as Biologic Drugs and Vaccines
- Ex Vivo Production of Large Quantities of EVs for Therapeutics: Challenges and Opportunities
- Exosomes-based Diagnostics/Liquid Biopsy Development
- Diagnostics Markers Carried by Exosomes
- Liquid Biopsy Enabled by Analyzing Exosome Biomarker Cargo
- Exosomes/EVs-based Drug Delivery Approaches
- Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
- Stem Cell-based EVs for Regenerative Medicine
- Mesenchymal Stem Cells (MSCs): EVs as a Mediator of Cell Therapy?
- The Intersection of Exosomes and Viruses
- Is there a Deep Connection Between Exosomes/EVs and Animal Viruses?
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateJohnathon Anderson, Assistant Professor, University of California Davis Health
Chris Baldwin, Chief Commercial Officer, Exopharm Ltd.
Rachel DeRita, Director, Extracellular Vesicle Core Facility, University of Pennsylvania School of Veterinary medicine
Jack Keene, James B. Duke Professor, Duke University Medical Center
Aurelio Lorico, Professor of Pathology, Touro University Nevada
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2021-02-25 00:00:002021-02-26 00:00:00Europe/LondonExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and TherapeuticsExtracellular Vesicles (EV)-Exosomes: Diagnostics, Delivery and Therapeutics in San Diego, CaliforniaSan Diego, CaliforniaSELECTBIOenquiries@selectbiosciences.com
